{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:43:10Z","timestamp":1792489390479,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,21]]},"DOI":"10.7759\/cureus.16530","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T11:35:10Z","timestamp":1626867310000},"source":"Crossref","is-referenced-by-count":1,"title":["Rapid Onset of Weight Gain and Liver Dysfunction Successfully Treated With Nutrition and Exercise"],"prefix":"10.7759","author":[{"given":"Hiroteru","family":"Kamimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Tsujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunaga","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Komoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Terai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease--meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi ZM","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease--meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016, 64:73-84. 10.1002\/hep.28431","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.02.032","article-title":"NKT-cell subsets: promoters and protectors in inflammatory liver disease","volume":"59","author":"Kumar V","year":"2013","unstructured":"Kumar V. NKT-cell subsets: promoters and protectors in inflammatory liver disease. J Hepatol. 2013, 59:618-620. 10.1016\/j.jhep.2013.02.032","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.04.013","article-title":"Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial","volume":"59","author":"Wong VW","year":"2013","unstructured":"Wong VW, Chan RS, Wong GL, et al.. Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial. J Hepatol. 2013, 59:536-542. 10.1016\/j.jhep.2013.04.013","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00292-020-00800-0","article-title":"[Histopathological diagnosis and differential diagnosis of nonalcoholic fatty liver disease]","volume":"41","author":"Theurer S","year":"2020","unstructured":"Theurer S, K\u00e4lsch J, Schwertheim S, Kathemann S, Baba HA. [Histopathological diagnosis and differential diagnosis of nonalcoholic fatty liver disease]. Der Pathologe. 2020, 41:434-443. 10.1007\/s00292-020-00800-0","journal-title":"Der Pathologe"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/nu12061583","article-title":"Effects of COVID-19 home confinement on eating behaviour and physical activity: results of the ECLB-COVID19 International Online survey","volume":"12","author":"Ammar A","year":"2020","unstructured":"Ammar A, Brach M, Trabelsi K, et al.. Effects of COVID-19 home confinement on eating behaviour and physical activity: results of the ECLB-COVID19 International Online survey. Nutrients. 2020, 12:1583. 10.3390\/nu12061583","journal-title":"Nutrients"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2020.100171","article-title":"Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease","volume":"2","author":"Golabi P","year":"2020","unstructured":"Golabi P, Gerber L, Paik JM, Deshpande R, de Avila L, Younossi ZM. Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease. JHEP Rep. 2020, 2:100171. 10.1016\/j.jhepr.2020.100171","journal-title":"JHEP Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.12.029","article-title":"Prevalence of metabolic syndrome in retired National Football League players","volume":"101","author":"Miller MA","year":"2008","unstructured":"Miller MA, Croft LB, Belanger AR, Romero-Corral A, Somers VK, Roberts AJ, Goldman ME. Prevalence of metabolic syndrome in retired National Football League players. Am J Cardiol. 2008, 101:1281-1284. 10.1016\/j.amjcard.2007.12.029","journal-title":"Am J Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study","volume":"42","author":"Bedogni G","year":"2005","unstructured":"Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology. 2005, 42:44-52. 10.1002\/hep.20734","journal-title":"Hepatology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis","volume":"51","author":"Promrat K","year":"2010","unstructured":"Promrat K, Kleiner DE, Niemeier HM, et al.. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology. 2010, 51:121-129. 10.1002\/hep.23276","journal-title":"Hepatology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04122.x","article-title":"Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease","volume":"30","author":"Vilar Gomez E","year":"2009","unstructured":"Vilar Gomez E, Rodriguez De Miranda A, Gra Oramas B, et al.. Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease. Aliment Pharmacol Ther. 2009, 30:999-1009. 10.1111\/j.1365-2036.2009.04122.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28416","article-title":"Weight loss results in significant improvements in quality of life for patients with nonalcoholic fatty liver disease: a prospective cohort study","volume":"63","author":"Tapper EB","year":"2016","unstructured":"Tapper EB, Lai M. Weight loss results in significant improvements in quality of life for patients with nonalcoholic fatty liver disease: a prospective cohort study. Hepatology. 2016, 63:1184-1189. 10.1002\/hep.28416","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo P","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, et al.. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015, 149:389-397.e10. 10.1053\/j.gastro.2015.04.043","journal-title":"Gastroenterology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2009.274","article-title":"A 12-week aerobic exercise program reduces hepatic fat accumulation and insulin resistance in obese, Hispanic adolescents","volume":"18","author":"van der Heijden GJ","year":"2010","unstructured":"van der Heijden GJ, Wang ZJ, Chu ZD, Sauer PJ, Haymond MW, Rodriguez LM, Sunehag AL. A 12-week aerobic exercise program reduces hepatic fat accumulation and insulin resistance in obese, Hispanic adolescents. Obesity (Silver Spring). 2010, 18:384-390. 10.1038\/oby.2009.274","journal-title":"Obesity (Silver Spring)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23129","article-title":"Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss","volume":"50","author":"Johnson NA","year":"2009","unstructured":"Johnson NA, Sachinwalla T, Walton DW, Smith K, Armstrong A, Thompson MW, George J. Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology. 2009, 50:1105-1112. 10.1002\/hep.23129","journal-title":"Hepatology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.08.023","article-title":"Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: a systematic review","volume":"66","author":"Hashida R","year":"2017","unstructured":"Hashida R, Kawaguchi T, Bekki M, et al.. Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: a systematic review. J Hepatol. 2017, 66:142-152. 10.1016\/j.jhep.2016.08.023","journal-title":"J Hepatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12649","article-title":"Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis","volume":"46","author":"Fujimori N","year":"2016","unstructured":"Fujimori N, Tanaka N, Shibata S, et al.. Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis. Hepatol Res. 2016, 46:1019-1027. 10.1111\/hepr.12649","journal-title":"Hepatol Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","article-title":"Controlled attenuation parameter (CAP): a novel VCTE\u2122 guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes","volume":"36","author":"Sasso M","year":"2010","unstructured":"Sasso M, Beaugrand M, de Ledinghen V, et al.. Controlled attenuation parameter (CAP): a novel VCTE\u2122 guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol. 2010, 36:1825-1835. 10.1016\/j.ultrasmedbio.2010.07.005","journal-title":"Ultrasound Med Biol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(19)30383-8","article-title":"FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study","volume":"5","author":"Newsome PN","year":"2020","unstructured":"Newsome PN, Sasso M, Deeks JJ, et al.. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study. Lancet Gastroenterol Hepatol. 2020, 5:362-373. 10.1016\/S2468-1253(19)30383-8","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/41.4.810","article-title":"Assessment of fat-free mass using bioelectrical impedance measurements of the human body","volume":"41","author":"Lukaski HC","year":"1985","unstructured":"Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr. 1985, 41:810-817. 10.1093\/ajcn\/41.4.810","journal-title":"Am J Clin Nutr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.06.030","article-title":"Obesity and risk of nonalcoholic fatty liver disease: a comparison of bioelectrical impedance analysis and conventionally-derived anthropometric measures","volume":"15","author":"Balakrishnan M","year":"2017","unstructured":"Balakrishnan M, El-Serag HB, Nguyen T, Hilal J, Kanwal F, Thrift AP. Obesity and risk of nonalcoholic fatty liver disease: a comparison of bioelectrical impedance analysis and conventionally-derived anthropometric measures. Clin Gastroenterol Hepatol. 2017, 15:1965-1967. 10.1016\/j.cgh.2017.06.030","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-00052","article-title":"Fatty liver has stronger association with insulin resistance than visceral fat accumulation in nonobese Japanese men","volume":"3","author":"Kadowaki S","year":"2019","unstructured":"Kadowaki S, Tamura Y, Someya Y, et al.. Fatty liver has stronger association with insulin resistance than visceral fat accumulation in nonobese Japanese men. J Endocr Soc. 2019, 3:1409-1416. 10.1210\/js.2019-00052","journal-title":"J Endocr Soc"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/64260-rapid-onset-of-weight-gain-and-liver-dysfunction-successfully-treated-with-nutrition-and-exercise","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:32:22Z","timestamp":1707507142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/64260-rapid-onset-of-weight-gain-and-liver-dysfunction-successfully-treated-with-nutrition-and-exercise"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,21]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.16530","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,21]]}}}